Monday, January 06, 2020 5:46:36 AM
The entire interview is here:
https://www.phacilitate.co.uk/article/preparing-commercialisation-right-cdmo" rel="nofollow" target="_blank" >https://www.phacilitate.co.uk/article/preparing-commercialisation-right-cdmo[tag]Phacilitate interview/tag]
If they expanded from 6 to 22 suites that is a factor of 22/6. In the trial they were maxed out at about 75/y. That makes about 300/y. But we know they are growing customers so you can not assume all 300.
Regardless, 22 clean rooms could not possibly turn 5000 batches a year as asserted.
Buy if LP said 5000 as a forward looking statement, it must be true. Right?
https://www.phacilitate.co.uk/article/preparing-commercialisation-right-cdmo" rel="nofollow" target="_blank" >https://www.phacilitate.co.uk/article/preparing-commercialisation-right-cdmo[tag]Phacilitate interview/tag]
Cognate has recently opened up 16 additional suites, for a total of 22 suites of manufacturing capacity to support products for both EU and US markets and we’re well on our way to being able to support commercial-scale production.
If they expanded from 6 to 22 suites that is a factor of 22/6. In the trial they were maxed out at about 75/y. That makes about 300/y. But we know they are growing customers so you can not assume all 300.
Regardless, 22 clean rooms could not possibly turn 5000 batches a year as asserted.
Buy if LP said 5000 as a forward looking statement, it must be true. Right?
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
